Kenji Sawa

2.8k total citations
40 papers, 312 citations indexed

About

Kenji Sawa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Kenji Sawa has authored 40 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Kenji Sawa's work include Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Research Studies (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Kenji Sawa is often cited by papers focused on Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Research Studies (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Kenji Sawa collaborates with scholars based in Japan, Venezuela and South Korea. Kenji Sawa's co-authors include Tomoya Kawaguchi, Kazuto Hirata, Kazuhisa Asai, Tetsuya Watanabe, Koichi Takayama, Yoshinobu Ohsaki, Shigeki Mitsuoka, Hiroyasu Kaneda, Tomohiro Suzumura and Naoki Yoshimoto and has published in prestigious journals such as PLoS ONE, Cancer and Cancer Research.

In The Last Decade

Kenji Sawa

37 papers receiving 311 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kenji Sawa 221 138 41 41 23 40 312
Ming-Shian Tsai 66 0.3× 163 1.2× 60 1.5× 43 1.0× 14 0.6× 10 305
A. Rastogi 144 0.7× 163 1.2× 57 1.4× 62 1.5× 47 2.0× 35 512
Monika Hofstetter 45 0.2× 33 0.2× 66 1.6× 23 0.6× 4 0.2× 10 217
Maria Grazia Maglione 36 0.2× 45 0.3× 17 0.4× 21 0.5× 50 2.2× 21 255
Weijun Fan 206 0.9× 84 0.6× 47 1.1× 24 0.6× 1 0.0× 28 309
Okamoto 80 0.4× 65 0.5× 55 1.3× 14 0.3× 4 0.2× 30 346
Mohammad R. Nikmaneshi 25 0.1× 67 0.5× 41 1.0× 26 0.6× 5 0.2× 21 235
Arnav Srivastava 316 1.4× 52 0.4× 152 3.7× 42 1.0× 3 0.1× 32 424
Yuji Negoro 155 0.7× 160 1.2× 18 0.4× 23 0.6× 2 0.1× 39 361

Countries citing papers authored by Kenji Sawa

Since Specialization
Citations

This map shows the geographic impact of Kenji Sawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Sawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Sawa more than expected).

Fields of papers citing papers by Kenji Sawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Sawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Sawa. The network helps show where Kenji Sawa may publish in the future.

Co-authorship network of co-authors of Kenji Sawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Sawa. A scholar is included among the top collaborators of Kenji Sawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Sawa. Kenji Sawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sawa, Kenji, et al.. (2024). Immune Checkpoint Inhibitor Is Associated with Improved Survival in Advanced Non-small Cell Lung Cancer Occurring in Patients with Autoimmune Disease. Biological and Pharmaceutical Bulletin. 47(2). 454–461. 1 indexed citations
3.
Sawa, Kenji, et al.. (2024). Immunotherapy and Overall Survival Among Patients With Advanced Non–Small Cell Lung Cancer and Obesity. JAMA Network Open. 7(8). e2425363–e2425363. 8 indexed citations
4.
Yashiro, Masakazu, Akira Sugimoto, Kenji Sawa, et al.. (2024). Insulin-like growth factor 1 receptor expression correlates with programmed death ligand 1 expression and poor survival in non-small cell lung cancer. PLoS ONE. 19(10). e0297397–e0297397.
5.
Nakahama, Kenji, Naoki Yoshimoto, Mitsuru Fukui, et al.. (2023). Vimentin expression correlates with immune checkpoint inhibitor efficacy in non–small cell lung cancer. Cancer. 129(15). 2297–2307. 2 indexed citations
6.
7.
Sawa, Kenji, Takumi Imai, Tetsuya Kimura, et al.. (2023). Renin–angiotensin–aldosterone system inhibitors are associated with improved paclitaxel-induced peripheral neuropathy in lung cancer: a study using administrative claims data. Supportive Care in Cancer. 31(12). 730–730. 3 indexed citations
8.
9.
Nakahama, Kenji, Naoki Yoshimoto, Mitsuru Fukui, et al.. (2023). Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 92(5). 381–390. 4 indexed citations
10.
Yashiro, Masakazu, Naoki Yoshimoto, Akira Sugimoto, et al.. (2023). RBM17 Expression Is Associated With the Efficacy of ICI Monotherapy in NSCLC With Low PD-L1 Expression. Anticancer Research. 43(10). 4663–4672. 3 indexed citations
11.
Sawa, Kenji, Takumi Imai, Akira Sugimoto, et al.. (2023). Lack of Association Between Immunotherapy and Improvement of Survival for Non-small Cell Lung Cancer Patients With Hemodialysis: A Nationwide Retrospective Cohort Study. Clinical Lung Cancer. 25(2). 144–150.e3. 2 indexed citations
12.
Sawa, Kenji, Hiroyasu Kaneda, Kenji Nakahama, et al.. (2022). P28-11 The therapeutic efficacy of osimertinib in non-small cell lung cancer with malignant pleural effusion. Annals of Oncology. 33. S523–S523.
13.
Sawa, Kenji, Izumi Sato, Masato Takeuchi, & Koji Kawakami. (2022). Risk of pneumonitis in non-small cell lung cancer patients with preexisting interstitial lung diseases treated with immune checkpoint inhibitors: a nationwide retrospective cohort study. Cancer Immunology Immunotherapy. 72(3). 591–598. 7 indexed citations
14.
Sawa, Kenji, Jun Oyanagi, Mitsuru Fukui, et al.. (2021). Tumor microenvironment disparity in multiple primary lung cancers: Impact of non-intrinsic factors, histological subtypes, and genetic aberrations. Translational Oncology. 14(7). 101102–101102. 11 indexed citations
15.
Oyanagi, Jun, Kenji Sawa, Mitsuru Fukui, et al.. (2021). Mutational landscape of multiple primary lung cancers and its correlation with non-intrinsic risk factors. Scientific Reports. 11(1). 5680–5680. 18 indexed citations
16.
Kaneda, Hiroyasu, Kenji Sawa, Tomohiro Suzumura, et al.. (2020). Early-onset meningitis associated with atezolizumab treatment for non-small cell lung cancer: case report and literature review. Investigational New Drugs. 38(6). 1901–1905. 5 indexed citations
17.
Koh, Yasuhiro, Hiroyasu Kaneda, Kenji Sawa, et al.. (2020). Can smoking duration alone replace pack-years to predict the risk of smoking-related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in Japan. BMJ Open. 10(9). e035615–e035615. 6 indexed citations
18.
19.
20.
Hirata, Kazuto, Koichi Takayama, Tomoya Kawaguchi, Kenji Sawa, & Yoshinobu Ohsaki. (2014). The Diagnosis and Treatment of Lung Cancer. Nihon Naika Gakkai Zasshi. 103(6). 1360–1374. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming-Shian Tsai Breakdown of academic impact, for papers by A. Rastogi Breakdown of academic impact, for papers by Monika Hofstetter Breakdown of academic impact, for papers by Maria Grazia Maglione Breakdown of academic impact, for papers by Weijun Fan Breakdown of academic impact, for papers by Okamoto Breakdown of academic impact, for papers by Mohammad R. Nikmaneshi Breakdown of academic impact, for papers by Arnav Srivastava Breakdown of academic impact, for papers by Yuji Negoro
Rankless by CCL
2026